As an approach to the construction of microsclerodermins (1), the three building blocks 2, 3, and 4 were efficiently prepared from the carboxylic acids 6, 16, and 28.
Introduction
Microsclerodermins have been isolated from the lithistid marine sponge Microscleroderma sp. by Faulkner and co-workers.
1 They are a family of complex cyclic peptides that display potent anti-fungal and anti-proliferative activities. One of the representative peptides are microsclerodermins A and B whose structures have been determined to be 1a and 1b, respectively, as shown in Fig. 1 . Our continuing interests in the synthesis of biologically active aquatic natural peptides 2 led to synthesize micro-sclerodermins. Toward this end, we have already accomplished the synthesis of four requisite building blocks: 3 the tryptophan derivative 2, 3d the hydroxypyrrolidinone equivalent 3, 3d 4-amino-3-hydroxybutanoic acid (GABOB) derivative 4, 3d and AMMTD 5, 3a-c,e shown in Fig. 1 . We now report the details of the synthesis of 2-4.
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Figure 1
Results and Discussion
We first synthesized the tryptophan derivative 2. We have already developed 4 the method for the asymmetric synthesis of α-amino acids by alkylation of the imine 10 derived from glycine ester and optically active 2-hydroxy-3-pinanone (HyPN, 9). The alkylating agent 8 to carry out this method was prepared from 2-indolecarboxylic acid (6) by esterification with iodomethane, Mannich reaction, and then quaternization, as shown in Scheme 1. The corresponding bromo derivative was also prepared, but it was found to be labile and the chemical yield was variable. The imine 10 derived from (-)-HyPN (9) 4a,b was lithiated with lithium diisopropylamide (LDA) and the resulting enolate was alkylated with 8 to give the alkylated imine 11, which was directly treated under weak acidic conditions to remove the chiral auxiliary 9. The resulting amine was converted to the corresponding tert-butoxycarbonyl (Boc) derivative 2 with Boc 2 O. The enantiomeric excess of 2 was 87%, and it raised to 91% by recrystalization.
Scheme 4
These results suggest that the synthesis of microsclerodermins could proceed via theγ-lactone 21, which will give the keto-amide 20b, equivalent to the hemiaminal 20a, by alkaline hydrolysis, oxidation of the hydroxyl group, and amidation, as shown in Scheme 5.
Scheme 5
Thus, the γ -lactone trimethylsilylethyl (TMSE) ester 24 was prepared from 16 by transformation to the imidazolide, homologation with TMSE acetate, 9 catalytic removal of the benzyl function, reduction with sodium borohydride, and lactonization with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), as shown in Scheme 6. Attempted removal of the TMSE group with tetrabutylammonium fluoride (TBAF) did not give the γ-lactone 3b, but resulted in the formation of the α,β-unsaturated dicarboxylic acid 25.
10
To prepare 3b in more efficient way, the β-keto ester 17 was first transformed to the hydroxy dicarboxylic acid 26, which underwent the lactonization with EDC to give 3b, as shown in Scheme 6. The lactone 3b was fully characterized by its transformation to the sarcosine derivative 27. Thus, we could succeed in the efficient synthesis of 3b in shorter steps.
Scheme 6
Finally, the synthesis of the required GABOB derivative 4 started from dimethyl (R)-malate, which was regioselectively reduced according to the known method, 11 as shown in Scheme 7. The resulting diol 29 was converted to the hydroxy azide 31 via the tosylate 30. Catalytic hydrogenation of 31 in the presence of Boc 2 O 12 afforded the Boc derivative 32, whose methyl ester function was replaced with the trichloroethyl (Tce) one. The Tce ester 33 was finally converted to the required corresponding tert-butyldimethylsilyl (TBS) derivative 4.
Thus we have succeeded in the efficient synthesis of the required building blocks 2-4 for the construction of microsclerodermins. The methods utilized here will have broad applicability to the synthesis of the other natural products.
calcium hydride and stored over sodium hydroxide. N,N-Dimethylformamide (DMF) was dried over 4 molecular sieves. Triethylamine was dried over sodium hydroxide. All other commercially available reagents were used as received.
Methyl indole-2-carboxylate (7).
To a stirred solution of indole-2-carboxylic acid (6) (16.16 g, 100 mmol) in DMF (200 ml) was added KHCO 3 (11.01 g, 110 mmol) and MeI (6.82 ml, 110 mmol) at 0°C. The mixture was stirred for 18 h at room temperature. After dilution with ether (600 ml), the mixture was washed with water (200 ml x 2) and 1M aqueous KHSO 4 (200 ml x 2), aqueous saturated NaHCO 3 (200 ml), saturated brine (200 ml Pd/C (1g) under argon atmosphere at room temperature. The mixture was stirred for 1 h at room temperature under H 2 atmosphere. The mixture was filtered and concentrated in vacuo. The volatile amine was used for the next step without further purification.
In a 200 ml round bottled flask, equipped with a Dean Stark apparatus (molecular sieves type 4) and reflux condenser, the crude amine (41.4 mmol) was dissolved in benzene (60 ml), followed by addition of (-)-HyPN (9) 
(R)-tert-Butyl 3-(2-(methoxycarbonyl)indol-3-yl)-2-N-(tert-butoxycarbonyl)-aminopropionate (2).
To a stirred solution of the crude 11 (4.693 g, 9.9 mmol) in THF (40 ml) was added 15% aqueous citric acid (40 ml) at room temperature. The mixture was stirred for 1 day at room temperature. After evaporation of THF, EtOAc (30 ml) was added and the mixture was extracted with 15% aqueous citric acid (50 ml x 3). The aqueous layer was basified with NaHCO 3 in an ice bath, followed by salting out, and extracted with ether (100 ml x 3). The organic layer was washed with saturated brine (50 ml), dried over MgSO 4 , filtered, and concentrated in vacuo to give the crude amine 12 which was immediately used for the next step without further purification.
To a stirred solution of the crude amine (9.9 mmol) in dioxane (30 ml) was added Boc 2 O (4.3 g, 19.8 mmol) at room temperature. The mixture was stirred for 11.5 h at room temperature. After evaporation of the volatile, the residue was purified by column chromatography (silica gel BW-200, 120 g, hexane:EtOAc = 6:1 to 4:1) to give 2 (2.605 g, 63% in 3 steps, 87%ee) as a colorless solid.
The analytical sample was recrystallized with hexane/EtOAc to give 2 as colorless needles (91%ee) , 7.23; N, 6.69. Found: C, 62.94; H, 7.19; N, 6 .68; HPLC analysis for 2: column, Daicel Chiralcel OD; solvent, hexane/i-PrOH = 9:1; flow, 1.0 ml/min; retention time, 9.03, 9.70 min.
organic layer was washed with 1M aqueous KHSO 4 (10 ml), saturated brine (10 ml), dried over 
Boc-D-HomoSer-OBu t (15).
To a stirred solution of 14 (29.3 mg, 0.097 mmol) in THF (0.5 ml) was added 0.5N aqueous LiOH (0.22 ml, 0.11 mmol) at 0°C. The mixture was stirred for 6 h at 0°C.
After acidification with 1M aqueous KHSO 4 , the aqueous layer was dried over Na 2 SO 4 , filtered, and concentrated in vacuo to give the crude carboxylic acid, which was used for the next step without further purification.
To a stirred solution of the carboxylic acid (0.97 mmol) in THF (0.5 ml) was added Et 3 N (21 ml, 0.146 mmol) and ClCO 2 Et (14 ml, 0.146 mmol) successively at -10°C, followed by stirring for 30 min. Triethylammonium chloride was removed by filtration and washed with small amount of THF.
A solution of sodium borohydride (8 mg, 0.21 mmol) in water (0.5 ml) was added dropwise to the filtrate at 0°C, followed by stirring at 0°C for 30 min. After being quenched with 1M aqueous KHSO 4 (3 ml), the mixture was extracted with EtOAc (10 ml x 3), dried over Na 2 SO 4 , filtered, and concentrated in vacuo. THF (4 ml) was added the solution of imidazolide via canula, and rinsed with THF (2 ml). The reaction mixture was stirred for 20 h at room temperature. After dilution with EtOAc (100 ml), the mixture was washed with 1M aqueous KHSO 4 (30 ml), saturated brine (30 ml), dried over Na 2 SO 4 , filtered, and concentrated in vacuo. 
-Ethyl β-hydrogen (S)-3-oxo-4-N-(tert-butoxycarbonyl)aminoadipate (18).
To a stirred solution of 17 (48.6 mg, 0.15 mmol) in EtOAc (0.5 ml) was added 5% Pd/C (20 mg) under argon atmosphere at room temperature. The mixture was stirred for 1.5 h at room temperature under hydrogen atmosphere, filtered through a pad of celite, and concentrated in vacuo to give the carboxylic acid 18 as a colorless oil, which was used for the next step without further purification; 
(3S,4S)-3-N-(tert-butoxycarbonyl)amino-4-hydroxy-4-(ethoxycarbonyl)-methyl-pyrrolidin-2-o ne (3a) and (3S,4R)-3-N-(tert-butoxycarbonyl)amino-4-hydroxy-

4-(ethoxycarbonyl)methylpyrrolidin-2-one (epi-3a).
To a stirred solution of the crude carboxylic acid 18 (0.15 mmol) in THF (0.5 ml) was added Et 3 N (23 µl, 0.165 mmol) and ClCO 2 Et (16 µl, 0.165 mmol) successively at 0°C. The mixture was stirred for 3 h. Aqueous NH 3 (28%, 0.1 ml) was added to the reaction mixture. The mixture was stirred for 30 min at 0°C. After addition of water (3 ml), the mixture was extracted with EtOAc (10 ml x 3), dried over Na 2 SO 4 , filtered, and concentrated in vacuo. The residue was purified by column chromatography (silica gel BW-200, 7 g, hexane:EtOAc = 1:2) to give a diastereomeric mixture of 3a and epi-3a (30 mg, 86%) as a colorless solid. The analytical sample was purified by further column chromatography (silica gel BW-200, CHCl3:MeOH = 50:1 to 10:1) to give the diastereomeric pure 3a and epi-3a. 
(3S,4RS)-3-N-(tert-Butoxycarbonyl)amino-4-[(trimethylsilyl)ethyl]methyl-butyrolactone (24).
To a stirred solution of 22 (96 mg, 0.206 mmol) in EtOAc (1 ml) was added 5% Pd/C (40 mg) under argon atmosphere at room temperature. The mixture was stirred for 12 h under hydrogen atmosphere at room temperature, and filtered through a pad of celite, concentrated in vacuo to give the carboxylic acid 23 as a colorless oil, which was used for the next step without further purification.
To a stirred solution of the crude carboxylic acid 23 (0.206 mmol) in EtOH (1 ml) was added NaBH 4 (13 mg, 0.343 mmol) at 0°C. The mixture was stirred for 15 min at 0°C. The reaction mixture was quenched with 1M aqueous KHSO 4 (3 ml), extracted with CHCl 3 (10 ml x 3), dried over Na 2 SO 4 , filtered, and concentrated in vacuo to give the crude hydroxy acid as a colorless oil, which was used for the next step without further purification.
To a stirred solution of the crude hydroxy acid (0.206 mmol) in CH 2 Cl 2 (2 ml) was added EDC·HCl (62 mg, 0.325 mmol) and DMAP (3 mg, 0.025 mmol) successively at 0°C. The mixture was stirred at 0°C for 4 h. After dilution with ether (30 ml), the mixture was washed with 1M aqueous KHSO 4 (10 ml), saturated aqueous NaHCO 3 (10 ml), saturated brine (10 ml), dried over Anal. calcd for C 16 H 29 NO 6 Si: C, 53.46; H, 8.13; N, 3.90. Found: C, 53.22; H, 7.94; N, 3.74 .
(3RS,4S)-3-Hydroxy-4-(N-(tert-butoxycarbonyl)amino)adipic acid (26). To a stirred solution of
17 (128 mg, 0.325 mmol) in EtOH (1 ml) was added NaBH 4 (27 mg, 0.714 mmol) at -78°C. The mixture was stirred for 1 h at -78°C. Aqueous citric acid (15%, 3 ml) was added, and the mixture was allowed to warm to room temperature, and diluted with EtOAc (50 ml), washed with water (10 ml), saturated brine (10 ml), dried over Na 2 SO 4 , filtered, and concentrated in vacuo to give the crude alcohol as a pale yellow oil, which was used for the next step without further purification.
To a stirred solution of the crude alcohol (0.325 mmol) in THF (1 ml) was added dropwise 1N
aqueous NaOH (0.9 ml, 0.9 mmol) at 0°C. The mixture was stirred for 5 h at 0°C, then transferred to a separating funnel with water (50 ml). The aqueous layer was washed with CHCl 3 (10 ml x 2), acidified with 1M aqueous KHSO 4 at 0°C and salted out. The mixture was extracted with EtOAc (10 ml x 5), dried over Na 2 SO 4 , filtered, and concentrated in vacuo to give the crude 27, which was purified by recrystallization (EtOAc) to give 27 (92 mg, quant.) as a colorless solid: mp 148-151°C (50 ml x 2), saturated aqueous NaHCO 3 (50 ml), saturated brine (50 ml), dried over Na 2 SO 4 , filtered, and concentrated in vacuo. Boc-Lactone 27. To a stirred solution of 26 (345 mg, 1.25 mmol) in CH 2 Cl 2 (13 ml) and DMSO (13 ml) were added EDC·HCl (358 mg, 1.88 mmol) and DMAP (16 mg, 0.13 mmol) at 0°C. The mixture was stirred for 17 h at room temperature. After dilution with ether (100 ml), the mixture was washed with 1M aqueous KHSO 4 (30 ml), saturated brine (30 ml), dried over MgSO 4 , filtered, and concentrated in vacuo to give the crude lactone carboxylic acid (134 mg). The aqueous layer was salted out and extracted with ether (10 ml x 10). The combined organic solution was dried over MgSO 4 , filtered, and concentrated in vacuo to give the crude 3b (312 mg) as a colorless amorphous solid, which was used for the next step without further purification. (IR ν max (CHCl 3 ) 1786 cm -1 (lactone C=O) ).
To a stirred solution of Boc-MeGly-OTce (577 mg, 1.8 mmol) in CHCl 3 (4 ml) was added TFA (2 ml) at room temperature. The mixture was stirred for 1 h at room temperature., then concentrated in vacuo to give the light yellow residue. Toluene was added to the whole and the mixture was concentrated in vacuo. This work-up was repeated three times to remove the excess of TFA completely. The crude TFA salt was used for the next step without further purification.
To a stirred solution of the crude 3b and the crude TFA salt of H-MeGly-OTce were added BopCl (510 mg, 2.0 mmol) and Et 3 N (0.56 ml, 4.0mmol) at 0°C. The mixture was stirred for 2 days at 4°C. After dilution with EtOAc (100 ml), the mixture was washed with 1M aqueous KHSO 4 (30 ml), saturated aqueous NaHCO 3 (30 ml), dried over Na 2 SO 4 , filtered, and concentrated in vacuo. 
Methyl (R)-3,4-dihydroxybutanoate (29).
In a 300 ml, three necked, round-bottled flask mounted with a reflux condenser and thermometer was placed a solution of (R)-dimethyl malate (28) (5 ml, 37.7 mmol) in THF (80 ml). To this was added 10.0-10.2 M borane-methylsulfide complex (3.9 ml, 39.0-39.8 mmol) dropwise at room temperature under stirring during 30 min. The solution was stirred at room temperature until evolution of hydrogen gas ceased (ca. 30 min). Then, the flask was cooled with a water-ice bath and stirring was continued for 30 min. To the solution was added NaBH 4 (72 mg, 1.90 mmol) in one portion (exothermic) under vigorous stirring at 0°C. When the exothermic reaction subsided, the water bath was removed and the reaction was stirred at room temperature for 30 min. MeOH (13 ml) and p-TsOH (360 mg, 1.9 mmol) were added to the reaction mixture, and the resulting slightly cloudy solution was stirred for 30 min at room temperature, followed by concentration to give a colorless gum. This was dissolved in benzene (40 ml) and stirred at room temperature for 15 h. After dilution with ether (200 ml), the mixture was washed with 1M aqueous KHSO 4 (30 ml x 2), saturated aqueous NaHCO 3 (30 ml) and saturated brine (30 ml), dried over MgSO 4 , filtered, and concentrated in vacuo. 
